Promoter holding
64.27%
CL
Canixa Life Sciences Private Limited. - Due diligence report
A 360° intelligence report on Canixa Life Sciences: trust score, financial health, credit view, compliance, directors, growth and distress s…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Canixa Life Sciences — 360° Intelligence Report
Generated from MCA filings & public records91/100
Trust Score
Low Risk
Canixa Life Sciences is assessed as Low Risk with a Trust Score of 91/100. Canixa Life Sciences is an active private limited indian non-government company incorporated in 2007, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 05 Aug 2026 from the latest processed filings. Canixa Life Sciences Private Limited. snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
91/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
81/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 5 open (37.13 cr) · 5 satisfied (2.45 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 6 | 48.0 cr |
| Union Bank Of India | 2 | 48.0 cr |
| Others | 2 | 48.0 cr |
Compliance Score: 81/100 Low Risk
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- Litigation present in 1 court forum(s).
- 14 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| RUPA KANUNGO | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRAVAT KUMAR KANUNGO | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
9 allotment(s) · 0 transfer(s)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 90 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Profit expanded 24% year-on-year.
Net margin improved to 0.86.
EPFO headcount growing - hiring signal.
Operating for 19+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
5 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence87/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment92/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 5 open charge(s) of 37.13 cr already registered.
- Compliance record supports lending.
Investor view92/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 4 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
27 May 2025
Charge created
Others - 75.50 Lakh
12 Nov 2024
Charge created
Hdfc Bank Limited - 15.00 Lakh
31 Mar 2024
Latest balance sheet
Filed with ROC
08 Feb 2024
Charge satisfied
Hdfc Bank Limited
08 Jan 2024
Charge satisfied
Hdfc Bank Limited
27 Nov 2023
Charge created
Others - 68.00 Lakh
09 Feb 2023
Charge created
Hdfc Bank Limited - 23.60 Lakh
07 Jul 2022
Charge satisfied
Hdfc Bank Limited
30 Jul 2019
Charge created
Hdfc Bank Limited - 13.67 Lakh
Charge created
Hdfc Bank Limited - 3.95 Lakh
Charge created
Hdfc Bank Limited - 7.20 Lakh
15 Mar 2019
Securities allotted
30000 Equity Shares - 78.00 Lakh raised
14 Mar 2018
Securities allotted
50000 Equity Shares - 82.00 Lakh raised
24 Mar 2017
Securities allotted
80000 Equity Shares - 72.00 Lakh raised
10
Key Observations
Auto-generated from the data aboveRevenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
14 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 9 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Srvs Solars Limited | U01112CT1998PLC012646 | Raipur, Chattisgarh, India |
| Pankajini International Private Limited | U14200OR2012PTC014822 | Bhubaneswar, Orissa, India |
| Homesol Inframart Private Limited | U18101MH2005PTC156807 | Mumbai, Maharashtra, India |
| Arafaath Food Industries Private Limited | U15132UP2008PTC034405 | Meerut, Uttar Pradesh, India |
| Lekhus Collections Private Limited | U18101DL2005PTC134625 | New Delhi, Delhi, India |
| Cosmefarma | U24246GA1981PLC000465 | Goa, Goa, India |
| Finecure Pharmaceuticals | U24230GJ2005PLC045724 | Ahmedabad, Gujarat, India |
| Dalmia Tea Packaging Private Limited | U01132WB2008PTC121975 | Siliguri, West Bengal, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Canixa Life Sciences before audits and certifications: compliance score 81/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Canixa Life Sciences: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Canixa Life Sciences - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 91/100, distress signals and MSME payment-delay disclosures - know whether Canixa Life Sciences pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Canixa Life Sciences - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Canixa Life Sciences an active company?
Canixa Life Sciences has MCA status “Active” with a compliance score of 81/100 (Low Risk).
Is Canixa Life Sciences financially healthy?
Canixa Life Sciences has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Canixa Life Sciences?
Its overall Trust Score is 91/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Canixa Life Sciences?
See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.
Does Canixa Life Sciences have loans or charges against its assets?
5 open charge(s) are registered against its assets, and 5 earlier charge(s) stand satisfied.
Is Canixa Life Sciences up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 81/100 (Low Risk).
Is it risky to lend to Canixa Life Sciences?
Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
